NAD+ is a coenzyme found in every living cell. It helps cells convert energy from nutrients into forms that can be used to support essential biological functions. It also participates in enzyme-driven processes involved in cellular signaling, DNA maintenance, and responses to metabolic stress.
Despite its growing visibility in wellness conversations, NAD+ is not simply an “energy molecule”—and it should not be treated as a shortcut to longevity. Understanding what NAD+ does, and what current research has not yet established, is the best place to begin.
KEY TAKEAWAYS
• NAD+ is a coenzyme that every cell uses to help convert nutrients into usable energy.
• It also supports processes involved in cellular signaling, DNA maintenance, and responses to metabolic stress.
• NAD+ is biologically important, but it should not be viewed as a shortcut to longevity; human research on NAD+–related supplementation is still developing.
NAD+ in one sentence
NAD+—short for nicotinamide adenine dinucleotide—is a molecule that helps cells transfer electrons during metabolic reactions. It also serves as a required substrate for enzymes involved in cellular signaling and maintenance.
Cells continually cycle between NAD+ and its reduced form, NADH. In simplified terms, NAD+ accepts electrons as nutrients are processed, while NADH carries those electrons into pathways involved in producing ATP—the form of energy cells can readily use.
How NAD+ supports cellular energy
Cells require a continuous supply of usable energy to maintain their everyday functions. Much of this energy is supplied through ATP, a molecule that can be produced as carbohydrates, fats, and proteins move through interconnected metabolic pathways.
NAD+ plays an essential supporting role in these reactions. When it accepts electrons, NAD+ becomes NADH. In cells with mitochondria, NADH can then deliver those electrons to the electron transport chain, helping establish the conditions used to produce ATP. NAD+ is regenerated in the process, allowing the cycle to continue.
Beyond energy: signaling and cellular maintenance
NAD+ is also used by several families of enzymes, including sirtuins, PARPs, and CD38-related enzymes. These enzymes participate in processes associated with gene regulation, responses to DNA damage, metabolic adaptation, and cellular signaling.
This broader role is one reason NAD+ has attracted substantial scientific interest. However, involvement in an important biological pathway does not automatically mean that increasing NAD+ will produce a specific health outcome. The clinical evidence in humans is still developing.
NAD+ and aging: what research suggests
Research has identified age-related changes in NAD+ metabolism across multiple tissues and experimental models. These changes may reflect a combination of reduced production, increased consumption, metabolic stress, inflammation, and shifts in the activity of NAD+-dependent enzymes.
Much of the strongest mechanistic evidence comes from laboratory and animal research. Human studies are growing, but NAD+ levels do not necessarily change in the same way across every tissue or individual. Age, health status, lifestyle, and measurement methods can all influence the findings.
For this reason, it is more accurate to view NAD+ as one part of a complex biological network—not as a single explanation for aging or a standalone measure of cellular health.
How the body makes NAD+
The body maintains its NAD+ supply through several interconnected pathways. It can build NAD+ from tryptophan and forms of vitamin B3, while also recycling nicotinamide released when NAD+-consuming enzymes perform their functions.
One important route is the salvage pathway. In this pathway, nicotinamide is converted into nicotinamide mononucleotide, or NMN, which is then converted into NAD+ by NMNAT enzymes. Nicotinamide riboside, or NR, can also enter NAD+ metabolism after first being converted into NMN.
Because NAD+ is continuously produced, used, and recycled, its availability reflects a dynamic balance—not a single dietary input or one isolated reaction.
Where NAD+ precursors fit in
Nicotinamide, nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN) can all contribute to NAD+ metabolism through different biochemical routes. This has led researchers to study whether providing these precursors can influence NAD+-related biomarkers and aspects of human physiology.
Human trials have reported that oral NR or NMN can increase certain NAD+-related metabolites in blood under some study conditions. Findings for broader outcomes—including physical function, metabolic measures, and other indicators of health—have been less consistent. Studies vary in participant characteristics, dose, duration, and the outcomes measured.
An increase in a biomarker is not the same as a demonstrated clinical benefit. Larger and longer-duration human studies are still needed to determine which effects are meaningful, for whom, and under what conditions.
A measured perspective
NAD+ is fundamental to cellular metabolism and participates in biological processes extending well beyond energy transfer. That foundational role provides a strong scientific reason to study NAD+ metabolism and the compounds that contribute to it.
What remains less certain is how changes in NAD+-related biomarkers translate into durable, meaningful outcomes in people. The most useful perspective is therefore neither dismissal nor exaggeration, but careful attention to the quality, limits, and continuing development of the evidence.
Understanding the mechanism is the beginning—not the conclusion.
References
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22, 119–141 (2021).
Rajman, L., Chwalek, K., & Sinclair, D. A. Therapeutic potential of NAD-boosting molecules: The in vivo evidence. Cell Metabolism, 27(3), 529–547 (2018).
Yoshino, M., et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229 (2021).
Martens, C. R., et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9, 1286 (2018).
Irie, J., et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 67(2), 153–160 (2020).
This article is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not a substitute for advice from a qualified healthcare professional.